Literature DB >> 23602314

Commitment to assessment and treatment: comprehensive care for patients gravely disabled by alcohol use disorders.

Ryan P McCormack1, Arthur R Williams, Lewis R Goldfrank, Arthur L Caplan, Stephen Ross, John Rotrosen.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23602314     DOI: 10.1016/S0140-6736(12)62206-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Imaging of frequent emergency department users with alcohol use disorders.

Authors:  Baker H Hamilton; Amish Sheth; Ross T McCormack; Ryan P McCormack
Journal:  J Emerg Med       Date:  2014-01-10       Impact factor: 1.484

2.  Utilization of a Sobering Center for Acute Alcohol Intoxication.

Authors:  Shannon Smith-Bernardin; Adam Carrico; Wendy Max; Susan Chapman
Journal:  Acad Emerg Med       Date:  2017-08-08       Impact factor: 3.451

3.  Including frequent emergency department users with severe alcohol use disorders in research: assessing capacity.

Authors:  Ryan P McCormack; Timothy Gallagher; Lewis R Goldfrank; Arthur L Caplan
Journal:  Ann Emerg Med       Date:  2014-10-23       Impact factor: 5.721

4.  Resource-limited, collaborative pilot intervention for chronically homeless, alcohol-dependent frequent emergency department users.

Authors:  Ryan P McCormack; Lily F Hoffman; Stephen P Wall; Lewis R Goldfrank
Journal:  Am J Public Health       Date:  2013-10-22       Impact factor: 9.308

5.  Intensive Case Management for Addiction to promote engagement with care of people with severe mental and substance use disorders: an observational study.

Authors:  Stéphane Morandi; Benedetta Silva; Philippe Golay; Charles Bonsack
Journal:  Subst Abuse Treat Prev Policy       Date:  2017-05-25

6.  Non-employment histories of middle-aged men and women who died from alcohol-related causes: a longitudinal retrospective study.

Authors:  Tapio Paljärvi; Pekka Martikainen; Taina Leinonen; Tiina Pensola; Pia Mäkelä
Journal:  PLoS One       Date:  2014-05-29       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.